Accumulating evidence indicates that disruption of galanin signaling is associated with neuropsychiatric disease, but the precise functions of this neuropeptide remain largely unresolved due to lack of tools for experimentally disrupting its transmission in a cell typespecific manner. To examine the function of galanin in the noradrenergic system, widely thought to be an important source of galanin for modulation of emotional responses, we generated and crossed two novel knock-in mouse lines to create animals lacking galanin specifically in noradrenergic neurons (Gal cKO-Dbh ). We observed reduced levels of galanin peptide in pons, hippocampus, and prefrontal cortex of Gal cKO-Dbh mice, indicating that noradrenergic neurons are a major source of galanin to those brain regions, while midbrain and hypothalamic galanin levels were comparable to littermate controls. In these same brain regions, we observed no change in levels of norepinephrine or its major metabolite, suggesting that loss of galanin does not affect baseline noradrenergic synthesis or turnover. Gal cKO-Dbh mice had normal performance in tests of depression, learning, and motor-related behavior, but had an altered response in anxietyrelated tasks. Specifically, Gal cKO-Dbh mice showed increased marble and shock probe burying and had a reduced latency to eat in a novel environment, indicative of a more proactive coping strategy. Together, these findings indicate that noradrenergic neurons provide a significant source of galanin to discrete brain areas, and noradrenergic-specific galanin opposes adaptive coping responses.